Skip to content
World City Press – Lifestyle
Author:
UniXell Biotechnology Co., Ltd.
Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy
March 13, 2026